These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 14156122)
41. Use of buccal protease therapy in chronic bronchial asthma. FRANKEL DB; AARONSON AL; EHRLICH NJ Ann Allergy; 1961 Dec; 19():1415-22. PubMed ID: 13894654 [No Abstract] [Full Text] [Related]
42. Studies on a proteolytic enzyme in human plasma. IX. Fibrinogen and fibrin as substrates for the proteolytic enzyme of plasma. RATNOFF OD J Clin Invest; 1953 Jun; 32(6):473-9. PubMed ID: 13052710 [No Abstract] [Full Text] [Related]
43. EFFECTS OF FIBRINOLYTIC AGENTS AND HEPARIN ON INTRAVASCULAR CLOT LYSIS. LEWIS JH; KERBER CW; WILSON JH Am J Physiol; 1964 Nov; 207():1044-8. PubMed ID: 14237447 [No Abstract] [Full Text] [Related]
44. CLINICAL TRIAL OF EPSILON-AMINOCAPROIC ACID IN SEVERE HAEMOPHILIA. GORDON AM; MCNICOL GP; DUBBER AH; MCDONALD GA; DOUGLAS AS Br Med J; 1965 Jun; 1(5451):1632-5. PubMed ID: 14295319 [No Abstract] [Full Text] [Related]
45. FIBRINOGEN AS A PART OF PLATELET STRUCTURE. GOKCEN M; YUNIS E Nature; 1963 Nov; 200():590-1. PubMed ID: 14082244 [No Abstract] [Full Text] [Related]
46. METHOD OF ANTIPLASMIN ASSAY IN HUMAN PLASMA. MAKI M; SAITO H; YONEYA T Tohoku J Exp Med; 1964 Jul; 83():168-78. PubMed ID: 14216987 [No Abstract] [Full Text] [Related]
47. IN VIVO ACTIVATION OF THE FIBRINOLYTIC SYSTEM OF THE CAT. EFFECT OF STREPTOKINASE, TRYPSIN AND GLYCEROL. FLEMING LB; CLIFFTON EE J Surg Res; 1965 Apr; 5():153-65. PubMed ID: 14279210 [No Abstract] [Full Text] [Related]
48. THE INHIBITION OF TRASYLOL OF FIBRINOLYTIC ACTIVITY ASSOCIATED WITH CARDIOVASCULAR OPERATIONS. TICE DA; WORTH MH; CLAUSS RH; REED GH Surg Gynecol Obstet; 1964 Jul; 119():71-4. PubMed ID: 14179354 [No Abstract] [Full Text] [Related]
49. STUDIES ON THE RELATIONSHIP BETWEEN FIBRIN-STABILIZING FACTOR, CALCIUM AND INHIBITION OF FIBRINOLYSIS. TYLER HM; LACK CH Clin Sci; 1965 Jun; 28():527-36. PubMed ID: 14316258 [No Abstract] [Full Text] [Related]
50. FATE OF STREPTOCOCCAL M PROTEIN AFTER EXPOSURE TO PLASMIN AND HUMAN LEUKOCYTES. KANTOR FS Yale J Biol Med; 1964 Feb; 36(4):259-67. PubMed ID: 14119861 [No Abstract] [Full Text] [Related]
51. [Treatment of patients with inflammatory changes of the deep portion of the lacrimal duct with proteolytic enzyme lavage (streptokinase and streptodornase); preliminary note]. DE BARROS JA; SIQUEIRA N Hospital (Rio J); 1959 Aug; 56():349-50. PubMed ID: 13797109 [No Abstract] [Full Text] [Related]
52. [FIBRINOLYSIS INHIBITORS AND DETERMINATION OF PHYSIOLOGICAL AND PATHOLOGICAL ANTIPLASMIN ACTIVITY]. MORIAU M; DE VRIES SI; DIK HJ Thromb Diath Haemorrh; 1964 Jan; 10():355-78. PubMed ID: 14113376 [No Abstract] [Full Text] [Related]
58. [A SYNTHETIC STUDY ON THE COMPARISON OF FIBRINOLYSIN DETERMINATIONS]. MIYATANI K; FUKUI I Rinsho Byori; 1965 Feb; 13():123-6. PubMed ID: 14327228 [No Abstract] [Full Text] [Related]
59. [PRESENT ORIENTATIONS ON THERAPY OF ACUTE ISCHEMIA OF THE LIMBS]. ZANNINI G; JOVINO R; SANTANGELO ML Policlinico Chir; 1964 Oct; 71():249-90. PubMed ID: 14245972 [No Abstract] [Full Text] [Related]
60. Fibrinolysin and related plasma esterases in patients with cirrhosis. PERNOKAS LN; BROWN M Gastroenterology; 1963 Jan; 44():44-7. PubMed ID: 13942515 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]